AURINIA PHARMACEUTICALS INC (AUPH) Stock Analyst Earnings Estimates
NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.6M -8.98% | 134M 193.86% | 175.513M 30.98% | 240.4M 36.97% | 279.89M 16.43% | 344.41M 23.05% | 416.3M 20.87% | 462.89M 11.19% | 496.08M 7.17% | 392.11M -20.96% | 422.35M 7.71% | 417.87M -1.06% | |
| EBITDA YoY % growth | -177.94M -72.87% | -108.79M 38.86% | -80.044M 26.42% | 39.372M 149.19% | 141.27M 258.81% | 191.76M 35.74% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -180.7M -73.25% | -111.5M 38.30% | -91.691M 17.77% | -1.565M 98.29% | 78.796M 5,134.28% | 126.2M 60.16% | 182.34M 44.48% | 218.16M 19.64% | 251.08M 15.09% | 172.77M -31.19% | 205.63M 19.02% | 209.13M 1.70% | |
| Operating Margin | -396.27% | -83.21% | -52.24% | -0.65% | 28.15% | 36.64% | 43.80% | 47.13% | 50.61% | 44.06% | 48.69% | 50.05% | |
| EPS YoY % growth | -1.41 -90.54% | -0.76 46.10% | -0.54 28.95% | 0.03 104.91% | 0.58 2,100.00% | 0.81 38.81% | 1.23 52.39% | 1.38 11.98% | 1.49 7.56% | 1.14 -23.62% | 1.23 8.08% | 1.23 0.28% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 91.41% | 0.11 457.00% | 0.12 1,124.00% | 0.13 27.50% | 0.15 1,037.50% |
| Revenue Q2Q % growth | 61.143M 35.59% | 63.801M 26.83% | 67.881M 18.69% | 67.881M 0.16% | 70.584M 15.44% |
| EBITDA Q2Q % growth | -2.346M 86.99% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.499M 105.05% | 15.759M 339.86% | 18.972M 4,402.04% | 19.533M 66.27% | 23.103M 1,441.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.10 211.11% | 0.02 | 0.08 | 553.59% |
| Q2 2024 Q2Q % growth | 0.01 112.50% | 0.01 | 0.00 | 17.69% |
| Q1 2024 Q2Q % growth | -0.03 83.33% | -0.14 | 0.11 | 78.48% |
| Q4 2023 Q2Q % growth | -0.19 -5.56% | -0.17 | -0.02 | -14.05% |
| Q3 2023 Q2Q % growth | -0.09 -50.00% | -0.17 | 0.08 | 47.21% |
| Q2 2023 Q2Q % growth | -0.08 68.00% | -0.19 | 0.11 | 57.22% |
| Q1 2023 Q2Q % growth | -0.18 33.33% | -0.23 | 0.05 | 20.30% |
| Q4 2022 Q2Q % growth | -0.18 28.00% | -0.28 | 0.10 | 35.33% |
| Q3 2022 Q2Q % growth | -0.06 84.62% | -0.17 | 0.11 | 65.10% |
| Q2 2022 Q2Q % growth | -0.25 32.43% | -0.23 | -0.02 | -9.75% |
| Q1 2022 Q2Q % growth | -0.27 32.50% | -0.27 | 0.00 | 0.91% |
| Q4 2021 Q2Q % growth | -0.25 -400.00% | -0.27 | 0.02 | 8.74% |
| Q3 2021 Q2Q % growth | -0.39 -39.29% | -0.34 | -0.05 | -14.87% |
| Q2 2021 Q2Q % growth | -0.37 -42.31% | -0.37 | 0.00 | 0.42% |
| Q1 2021 Q2Q % growth | -0.40 -166.67% | -0.37 | -0.03 | -7.44% |
| Q4 2020 Q2Q % growth | -0.05 93.59% | -0.25 | 0.20 | 79.93% |
| Q3 2020 Q2Q % growth | -0.28 -33.33% | -0.24 | -0.04 | -17.44% |
| Q2 2020 Q2Q % growth | -0.26 -52.94% | -0.24 | -0.02 | -10.29% |
| Q1 2020 Q2Q % growth | -0.15 -7.14% | -0.27 | 0.12 | 45.02% |
| Q4 2019 Q2Q % growth | -0.78 | -0.22 | -0.56 | -258.46% |
| Q3 2019 Q2Q % growth | -0.21 | -0.20 | -0.01 | -3.98% |
| Q2 2019 Q2Q % growth | -0.17 | -0.17 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.14 | -0.16 | 0.02 | 11.45% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 67.771M 24.32% | 58.847M | 8.924M | 15.16% |
| Q2 2024 Q2Q % growth | 57.192M 37.83% | 56.156M | 1.036M | 1.84% |
| Q1 2024 Q2Q % growth | 50.303M 46.19% | 48.403M | 1.9M | 3.93% |
| Q4 2023 Q2Q % growth | 45.095M 58.56% | 45.214M | -119K | -0.26% |
| Q3 2023 Q2Q % growth | 54.515M -2.27% | 39.275M | 15.24M | 38.80% |
| Q2 2023 Q2Q % growth | 41.494M 47.19% | 38.91M | 2.584M | 6.64% |
| Q1 2023 Q2Q % growth | 34.409M 59.08% | 28.432M | 5.977M | 21.02% |
| Q4 2022 Q2Q % growth | 28.44M 21.54% | 28.335M | 105K | 0.37% |
| Q3 2022 Q2Q % growth | 55.78M 280.23% | 36.913M | 18.867M | 51.11% |
| Q2 2022 Q2Q % growth | 28.19M 325.83% | 27.685M | 505K | 1.82% |
| Q1 2022 Q2Q % growth | 21.63M 2,276.92% | 20.158M | 1.472M | 7.30% |
| Q4 2021 Q2Q % growth | 23.4M -53.23% | 22.435M | 965K | 4.30% |
| Q3 2021 Q2Q % growth | 14.67M 48,800.00% | 14.156M | 514K | 3.63% |
| Q2 2021 Q2Q % growth | 6.62M 21,966.67% | 4.786M | 1.834M | 38.32% |
| Q1 2021 Q2Q % growth | 910K 2,933.33% | 3.229M | -2.319M | -71.82% |
| Q4 2020 Q2Q % growth | 50.03M 166,666.67% | 30.6K | 49.999M | 163,396.73% |
| Q3 2020 Q2Q % growth | 30K -86.96% | 31.447K | -1.447K | -4.60% |
| Q2 2020 Q2Q % growth | 30K | 34.343K | -4.343K | -12.65% |
| Q1 2020 Q2Q % growth | 30K | 37.74K | -7.74K | -20.51% |
| Q4 2019 Q2Q % growth | 30K | 68.003K | -38.003K | -55.88% |
| Q3 2019 Q2Q % growth | 230K | 44.064K | 185.936K | 421.97% |
| Q2 2019 Q2Q % growth | 30K | 48.195K | -18.195K | -37.75% |
| Q1 2019 Q2Q % growth | 30K | 47.94K | -17.94K | -37.42% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 122.79% |
| Revenue | 0% | 0% | 0% | 0.33% |